Multiple sclerosis (MS) is a disease of unknown etiology that is felt by many to be immunologically mediated. Corticosteroids have historically been used to treat acute exacerbations of MS and remain the treatment of choice, although new therapies for acute attacks are under development. Several immunosuppressive therapies have shown limited benefit in chronic progressive MS, and these modalities are reviewed in this article. Finally, several new drugs have shown promise in the symptomatic treatment of MS and are also reviewed.
|Original language||English (US)|
|Number of pages||13|
|State||Published - Jun 20 1990|
ASJC Scopus subject areas
- Pharmaceutical Science